Showing 1,021 - 1,040 results of 116,975 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( a ((non decrease) OR (nn decrease)) ))', query time: 1.51s Refine Results
  1. 1021

    EGCG decreases RSK2-mediated cell viability. by Hanyong Chen (320863)

    Published 2015
    “…Differences were evaluated using the Student’s t-test and the asterisk (*) indicates a significant decrease in viability in RSK2<sup>+/+</sup> MEFs compared to RSK2<sup>-/-</sup> MEFs (<i>p</i> < 0.05).…”
  2. 1022

    Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

    Published 2013
    “…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”
  3. 1023
  4. 1024
  5. 1025
  6. 1026
  7. 1027
  8. 1028
  9. 1029
  10. 1030
  11. 1031

    Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

    Published 2013
    “…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”
  12. 1032
  13. 1033
  14. 1034
  15. 1035
  16. 1036

    Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.d... by Chantal C. Clark (10684632)

    Published 2021
    “…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. This suggests that these therapies are beneficial for coping with COVID-19 associated hypercoagulability. …”
  17. 1037
  18. 1038
  19. 1039
  20. 1040